

Chukwuka Monye
Speaker/ 3 years ago

Topamax treatment anxiety
Following whistleblower lawsuits filed against johnson johnson subsidiaries over illegal marketing and promotion for the epilepsy drug topamax, the justice department has reached a settlement of 81 million with the drug makers.